Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barkhof

Showing results (31-40 of 396) with videos related to

Pageof 40
Sort By:
AJR. American Journal of Roentgenology|October 1, 1990
Intracranial ganglioglioma: MR imagingP R Algra, P Scheltens, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisoloneE L J Hoogervorst, C H Polman, F Barkhof
Neuroimaging Clinics of North America|May 22, 2001
T1 hypointensities and axonal lossF Barkhof, G B Karas, M A van Walderveen
Neuroscience Letters|May 12, 2000
Unbiased whole-brain analysis of gray matter loss in Alzheimer's diseaseS A Rombouts, F Barkhof, M P Witter, et al.
Neuropathology and Applied Neurobiology|March 27, 2004
Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosisL Bö, J J G Geurts, R Ravid, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2008
The distribution of new enhancing lesion counts in multiple sclerosis: further explorationsIj van den Elskamp, Dl Knol, Bmj Uitdehaag, et al.
Acta Neurochirurgica. Supplement|October 21, 1998
Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcomeS M Egeler-Peerdeman, F Barkhof, R Walchenbach, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 9, 2002
The role of MRI as a surrogate outcome measure in multiple sclerosisH F McFarland, F Barkhof, J Antel, et al.
European Neurology|January 1, 1994
Evidence for atrophy of the corpus callosum in Alzheimer's diseaseP Vermersch, P Scheltens, F Barkhof, et al.
Journal of Neuroimmunology|October 1, 1992
The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosisS T Frequin, F Barkhof, K J Lamers, et al.
Pageof 40

Showing results (31-40 of 396) with videos related to

Sort By:
Pageof 40
AJR. American Journal of Roentgenology|October 1, 1990
Intracranial ganglioglioma: MR imagingP R Algra, P Scheltens, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2002
Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisoloneE L J Hoogervorst, C H Polman, F Barkhof
Neuroimaging Clinics of North America|May 22, 2001
T1 hypointensities and axonal lossF Barkhof, G B Karas, M A van Walderveen
Neuroscience Letters|May 12, 2000
Unbiased whole-brain analysis of gray matter loss in Alzheimer's diseaseS A Rombouts, F Barkhof, M P Witter, et al.
Neuropathology and Applied Neurobiology|March 27, 2004
Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosisL Bö, J J G Geurts, R Ravid, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2008
The distribution of new enhancing lesion counts in multiple sclerosis: further explorationsIj van den Elskamp, Dl Knol, Bmj Uitdehaag, et al.
Acta Neurochirurgica. Supplement|October 21, 1998
Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcomeS M Egeler-Peerdeman, F Barkhof, R Walchenbach, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 9, 2002
The role of MRI as a surrogate outcome measure in multiple sclerosisH F McFarland, F Barkhof, J Antel, et al.
European Neurology|January 1, 1994
Evidence for atrophy of the corpus callosum in Alzheimer's diseaseP Vermersch, P Scheltens, F Barkhof, et al.
Journal of Neuroimmunology|October 1, 1992
The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosisS T Frequin, F Barkhof, K J Lamers, et al.
Pageof 40